Pediatric Leukemia Patient Follows in His Father’s Footsteps 

Jake Maguire was just three days away from his sixth birthday when he was diagnosed with acute lymphoblastic leukemia (ALL). Encouraged by his father, a gym teacher, the young Maguire was already in love with sports, especially baseball. Now 23 and over a decade out of treatment, that love is still strong, and Maguire is … Read more

Young Adult Cancer Patients Prove Powerful Advocates in Washington D.C.

Cancer has not stopped Bethany Ross and Jeremy Pivor from undertaking numerous adventures, from Pivor’s sailing trips on the high seas to Bethany’s forays into skydiving and outdoor rock climbing. It is also often the catalyst for their actions, such as when both Dana-Farber Brigham Cancer Center patients headed to Washington, D.C. to advocate on … Read more

Pediatric Oncology Pharmacist Stays On the Job With Colorectal Cancer

As a pediatric pharmacist located in Dana-Farber’s Jimmy Fund Clinic, Patrick never tires of seeing smiling, young cancer patients enjoying the clinic’s playroom. The resilience they display throughout infusions, blood draws, and other procedures not only inspires him, but it also serves as a source of resolve he carries into his ongoing cancer care. Patrick, … Read more

Study Provides First In-Depth Look at Major Mix-Ups in the Genomic Terrain of Pediatric High-Grade Glioma

Two major obstacles once stood in the way of exploring the basic biology of diffuse midline glioma in children. And one of them was the brain itself. The cancer, a subtype of high-grade glioma, forms in some of the most critical parts of the brain, in regions that control such basic functions as breathing, swallowing, … Read more

Advances in Myeloma, Breast Cancer, and Clinical Trials Equity: A Dana-Farber Research Update

Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more

Addressing the Impact of Poverty on Childhood Cancer

Approximately one in three children in the United States lives in a low-income home. For childhood cancer patients, living in a low-income home can have a significant impact: Poverty and associated factors are linked to poorer outcomes, even at large academic medical centers like Dana-Farber, according to research by Kira Bona, MD, MPH, a pediatric … Read more

Pediatric Leukemia Patient Takes LEAP to Remission on Precision Medicine Trial

First Cinthia Roman Manrique learned she had acute lymphoblastic leukemia (ALL). Then the 8-year-old Peru native was uprooted from her school, family, and friends when she flew with her mother in early 2017 to the United States — where chances of a cure for her high-risk cancer were better.  In the U.S., Cinthia’s challenges continued … Read more

A Decade Later, Pediatric Cancer Survivor Shares His Experience

Brian Regan knows how overwhelming it can be to hear the words “you have cancer” as a teenager. That is why, nearly a decade after his own diagnosis, he feels compelled to help young patients and families currently grappling with the physical and emotional challenges of treatment. Regan, 27, is a member of the Pediatric … Read more

Pediatric Patient with Leukemia in Remission after Treatment and Transplant

Rosemary Iwakura, 17, was experiencing strange symptoms before her acute lymphoblastic leukemia diagnosis (ALL) almost two years ago. She was unable to focus on her schoolwork or activities and fainted on several occasions at school and at home. “I thought; ‘People faint for many reasons,’” she recalls. “We weren’t sure if we were supposed to … Read more

Pediatric Patient with Rare Leukemia in Remission after Novel Treatment

Nytasha Jette was panicked when her two-month-old son, Elyahs Jones, was found to have an extraordinarily high white blood cell count — over 300,000 — during a regular check-up. The family physician noted that Jones had very pale hands and was worried that the child wasn’t getting proper blood flow. Jette rushed Jones to Dana-Farber/Boston … Read more

Fertility Preservation Program Offers Choices and Chances to Pediatric Cancer Patients

The shock of a new cancer diagnosis was still settling in for Isabel Nordby when she and her parents made a decision that could greatly impact the teenager’s future — if and when the time is right. Before starting her chemotherapy protocol for Ewing sarcoma in April 2020, Isabel, then 15, had one of her … Read more

After Wilms Tumor Treatment, First Grade is First Rate for Pediatric Cancer Survivor

The last two school years will be remembered for the tremendous challenges they presented students due to COVID-19, but rising second-grader Caroline McMahan and her family were ready for the pandemic’s limitations after what they had already endured. By the time the pandemic began, Caroline, 7, was already adept at washing up, masking up, and … Read more

Newborn Genetic Screening for Pediatric Cancer Risk Could Save Lives

Numerous genetic mutations increase children’s risk for various cancers. When they are detected early, cancers can potentially be caught at an early, more treatable stage — or avoided entirely. Could adding such “cancer predisposition” genes to routine newborn “heel-stick” screening save lives? Lisa Diller, MD, chief medical officer at the Dana-Farber/Boston Children’s Cancer and Blood … Read more

Looking for Cancer’s Achilles Heel: The Pediatric Cancer Dependency Map

Thanks to developments in precision medicine, some adult cancers are now treated with designer drugs that target the genetic mutations that caused them. But most children with cancer have not reaped the same benefits. Unlike adult cancers, childhood cancers carry few genetic mutations. And the mutations these tumors do have are typically harder to make … Read more

Cancer Care in Transgender Youth Patients: Things to Consider

If transgender youth and adults are undergoing (or planning) gender-affirming surgery, taking masculinizing or feminizing hormones, and they have cancer, these treatments can have implications for their care. Cancer treatments in turn can have implications for their gender-affirming care. Oncologists should take gender identity into account in making decisions about cancer treatment. This starts with … Read more